Jaypee Brothers
In Current Chapter
In All Chapters
X
Clear
X
GO
Normal
Sepia
Dark
Default Style
Font Style 1
Font Style 2
Font Style 3
Less
Normal
More
Adult Immunization (Monograph)
Alladi Mohan, SK Sharma, RK Singal, AK Agarwal
1:
Anthrax Vaccine
Anthrax as Bioterrorism Weapon
Wet dispersal
Dry dispersal
Clinical Aspects of Anthrax Infection
Cutaneous anthrax
Inhalational anthrax
Gastrointestinal anthrax
Prevalence and Risk Factors
Anthrax Toxin and Anthrax Vaccines
Vaccine Administration and Adverse Effects
Administration
Adverse effects
Precautions to avoid adverse effects
Potential Benefits of Anthrax Vaccination
Evaluation Aspects of an Efficacious and Novel Vaccine
Acknowledgements
Key Points
2:
Cholera Vaccines
Pathophysiology
Immunity in Cholera
Cholera Vaccines (Parenteral)
Cholera Vaccines (Oral)
Herd Immunity
Potential Uses of Oral Cholera Vaccines
Surveillance
Key Points
3:
Dengue Virus Vaccines
Clinical Presentation of Dengue
Feasibility of Dengue Vaccines
Obstacles in the Development of Dengue Vaccine
Dengue Virus Antigens and Immune Response
Pathogenesis of Dengue Haemorrhagic Fever
Antibody-dependent Enhancement of Dengue Virus Replication
Role of T-lymphocytes in Dengue Virus Infection
Cytokines in Patients with Dengue
Efforts to Produce Dengue Vaccines
Tetravalent Live Attenuated Vaccine
Chimeric Dengue Vaccine
DNA Dengue Vaccines
Inactivated Dengue Vaccines
Whole virus inactivated dengue vaccine
Recombinant subunit dengue vaccine
Clinical Trials of Dengue Vaccines
Precautions in Dengue Vaccine Formulations
Acknowledgements
Key Points
4:
Diphtheria, Tetanus and Acellular Pertussis Vaccines: Status in Adults
Diphtheria
Vaccine Era
Basis for Immunization Against Diphtheria in Adults
Indian Context
Basis for Immunization Against Tetanus in Adults
Basis for Immunization Against Pertussis in Adults
Vaccines Available for Adult Immunization Against Diphtheria, Tetanus and Pertussis
Diphtheria vaccine
Tetanus Vaccine
Acellular Pertussis Vaccine
Measurement of Immunity to Diphtheria, Tetanus, Pertussis Vaccine
Immunogenicity of Tdap in Adults
Safety and Reactogenicity of Tdap in Adults
Immunization in Special Circumstances
Tetanus prophylaxis after injuries
Immunization in immunocompromised host
Recommendations on Immunization Against Diphtheria, Tetanus and Pertussis in Indian Adults
Key Points
5:
Haemophilus influenzae Type b Vaccine
Epidemiology
Pathogen
Host
Morbidity
Carrier state
Meningitis
Pneumonitis
Others
Mortality
Drug resistance
Hib Vaccines
Characteristics
Unconjugated PRP
Conjugated Hib vaccines
Types of conjugated Hib vaccines
Immunogenicity
Anti-PRP antibody
Vaccine immunogenicity
Comparison of immunogenicity
Vaccine efficacy
Effect on carrier state
Impact of universal childhood vaccination
Vaccine schedule
Availability
Route
Schedule
Boosters
Side-effects
Local side-effects
Systemic side-effects
Indications
High-risk populations
Contraindications
Storage and handling
Hib combination vaccines
Cost-effectiveness of mass vaccination
6:
Hepatitis A Vaccine
Epidemiology
Hepatitis A Virus: Virology, Mode of Transmission and Infectivity
Clinical Manifestations, Diagnosis and Complications
Vaccine Source and Preparations
Immunogenicity
Safety Profile
Dosing Schedule
Recommendations: Developed Countries vis-a-vis India
Contraindications
Post-exposure Prophylaxis
Key Points
7:
Hepatitis B Vaccination
Burden of HBV Infection in India
Adults at Risk for HBV Infection
Persons at risk for infection by sexual exposure
Persons at risk for infection by percutaneous or mucosal exposure to blood
Injection-drug users
Household contacts of persons with chronic HBV infection
Inmates and staff of institutions for developmentally disabled persons in long-term care facilities
Persons at risk for occupational exposure to HBV
Chronic renal failure patients
Recipients of blood products
Persons with chronic liver disease
Human immunodeficiency virus positive persons
Adult Vaccination Schedules and Results of Vaccination
Vaccination of adults
Non-standard vaccine schedules
Immune memory
Prevaccination serologic testing for susceptibility
Poor or non-response to HBV vaccination, Postvaccination screening and response to revaccination
Groups requiring different vaccination doses or schedules
Booster doses
Vaccine Safety
Vaccine reactogenicity
Adverse events
Contraindications and precautions
Key Points
8:
Hepatitis E Virus Vaccine
Immunobiology of HEV
Vaccine Approaches
Immunoprophylaxis
Possible Vaccine Targets
Recombinant proteins expressed in prokaryotes
Proteins expressed in insect cells
Expression in yeast cells
Proteins expressed in plant cells
Nucleic acid based vaccines
Preclinical and Clinical Trials
Key Points
9:
Human Immunodeficiency Virus Vaccine
Pathogenesis and Immune Response
Obstacles for Vaccine Development
Concepts for Vaccine Development
Deoxyribonucleic acid (DNA) vaccines
Vector based vaccines
Subunit vaccines
Peptide vaccines
Virus likes particles
Live-attenuated vaccines
Killed/inactivated vaccines
Strategies Used for Candidate Vaccines
Prime and boost vaccine strategy
Use of adjuvant
Multiclade vaccine
Therapeutic HIV Vaccines
Vaccine Efficacy
Clinical Trials of HIV Vaccines
Ad5 trial
AIDSVAX trial
Ongoing HIV-1 Vaccine Trials
HIV-1 vaccine trials in India
Ethical Issues in HIV Vaccine Trials
Implementation Issues in HIV Vaccine Trials
Whom to vaccinate?
False sense of security
Vaccine induced seropositivity
Cost
Key Points
10:
Human Papillomavirus (HPV) Vaccine
Burden of Disease
Risk Factors and Association with Cervical Cancer
Types of Vaccine
Prevention of Cervical Cancer
Immunogenicity
Immunobridging trial in India
Efficacy
Gardasil®
Cervarix®
Efficacy in mid adult women (age 24-45 years)
Duration of Immunity
Prevention of Diseases Associated with HP-6 and −11
Efficacy in males
Vaccine Administration and Safety
Indian experience
Coadministration with Other Vaccines
Recommendations for Use of the HPV Vaccine in Developed Countries
Extrapolating to the Indian Setting
Impact of Vaccine Introduction on Screening Programs
Directions for Research
Key Points
11:
Influenza Vaccine
Disease Burden
Monthly distribution of viruses
Strategies for Controlling Influenza
Influenza Vaccine
Trivalent Inactivated Vaccine
Adverse events
Live-Attenuated Influenza Vaccine
Contraindications
Efficacy, Effectiveness and Protection
Avian or Swine Influenza
Key Points
12:
Japanese Encephalitis
The Pathogen
Epidemiology
Pathogenesis
Clinical Features
Diagnosis
Treatment
Prevention
Who Should be Vaccinated?
Vaccines Against Japanese Encephalitis
Mouse brain-derived inactivated vaccine
Cell culture-derived inactivated vaccine
Cell culture-derived live-attenuated vaccine
Genetically Engineered Vaccines
Acknowledgements
Key Points
13:
Leishmania Vaccine
Immunology of Leishmania Infections
Leishmaniasis and Leishmania Vaccine
Previous Leishmania Vaccines
Leish-111
Present and future studies with Leish-111f and MPL-SE vaccine
Key Points
14:
Leprosy Vaccines
Immunomodulatory Agents Available or Tried in Leprosy
BCG
Mycobacterium W
ICRC Strain
M. Habana
M Vaccae
BCG + Killed M Leprae
Comparative Efficacy of Candidate Vaccines Against Leprosy
Immunotherapy of Leprosy
Subunit and DNA Vaccines
Future Perspective
Key Points
15:
Immunization in Humans with Experimental Malaria Vaccines
Pre-Erythrocytic Vaccines
Pre-Erythrocytic Subunit Deoxyribonucleic Acid Vaccines
Blood Stage Vaccines
Synthetic peptide vaccine SpF66
A combination blood stage vaccine (MSP-1, MSP-2, RESA)
MSP-1-based vaccines
MSP-3 and GLURP
Apical membrane protein-1 (AMA-1)
Overview
Key Points
16:
MMR Vaccine
MMR Vaccine
Vaccine Administration and Adverse Reactions
Contraindications
Need in Adults
Extrapolating Adult MMR Vaccination to the Indian Setting
Key Points
17:
Meningococcal Vaccination
Epidemiology, Transmission, Pathogenesis and Immune Factors
Disease Burden
Risk Factors for Meningococcal Disease
Prevention of Meningococcal Disease
Chemoprophylaxis
Meningococcal disease and vaccination
Polysaccharide vaccines
Conjugate vaccines
Group B OMP vaccines
Vaccine Availability in India
Vaccine Administration, Contraindications and Adverse Effects
Polysaccharide vaccine
Conjugate vaccines
Vaccine efficacy, immunogenicity and kinetics of immune response
Vaccination Guidelines
Vaccination guidelines in Indian setting
Areas for Future Research
Key Points
18:
Pneumococcal Vaccine
Burden of Pneumococcal Infections
Risk Factors for Pneumococcal Infections
S. pneumoniae and Pneumococcal Vaccines
Vaccine Administration and Adverse Effects
Potential Benefits of Pneumococcal Vaccination
Recommendations for Use of PPV in Developed Countries
Evidence for the Recommendations
Extrapolating to the Indian Setting
Directions for Research
Acknowledgements
Key Points
19:
Rabies Immunization
Burden of the Disease
Modes of Transmission
Immunity against Rabies
Post-exposure Treatment
Decision to treat
Management of animal bite wound
Wound toilet
Application of antiseptic medication
Local infiltration of rabies immunoglobulins
Other measures
Passive Immunization by Rabies Immunoglobulin
Active immunization
Intramuscular regimens
Essen schedule (Five-dose intramuscular regimen)
Zagreb schedule
Indications
Site of inoculation
Storage and transportation
Reconstitution and storage
Adverse effects with tissue culture vaccines
Switch over from one brand of vaccine to the other
Intradermal regimens
Rationale for intradermal rabies vaccine administration
Vaccination schedules
General guidelines for intradermal inoculation of rabies vaccine
Intradermal rabies vaccines and regimens approved for use in India
Pre-exposure prophylaxis
Maintenance of vaccine vial in use
General considerations
Post-exposure Therapy for Previously Vaccinated Persons
Managing re-exposure following post-exposure treatment with tissue culture vaccines
Managing exposure following pre-exposure prophylaxis with tissue culture vaccines
Managing re-exposure following post-exposure treatment with nervous tissue vaccine
Protective level of antirabies antibody
Role of laboratory facilities in management of animal bite cases
Pre-exposure Prophylaxis
Counselling of Patients and Attendants
Effectiveness of Vaccination in Dogs
Personal Safety Against Rabies
Possible Reasons for Anti-Rabies Treatment Failure
Control of Rabies in Reservoir
Key Points
20:
Rotavirus Vaccines
Microbiology
Rotavirus Epidemiology in India
Rotavirus Infection and Immune Response
Is the Protection to Rotavirus Disease Induced by Vaccines Serotype Specific?
Mechanism of Disease
Development of Vaccines to Protect from Rotavirus Infection
Historical Overview of Rotavirus Vaccines
Rotashield® [Quadrivalent Live Oral Human-Rhesus (RRV) Reassortant]
RotaTeq® (Pentavalent Live Oral Human-Bovine, WC3 Reassortants)
Coadministration of RotaTeq® with Childhood Vaccines
UK based Bovine-Human Reassortant Vaccine
Rotarix® (Monovalent Human G1 Rotavirus Vaccine)
Coadministration of Rotarix® with Childhood Vaccines
RV3 Neonatal Strain Vaccine
116E Neonatal Strain Vaccine
Other Approaches to Rotavirus Vaccination
Introduction of Rotavirus Vaccine in India
Key Points
21:
Typhoid Vaccines
Disease Burden
Overview of the Disease
Prevention of Typhoid Fever
Typhoid vaccines
Vi capsular polysaccharide vaccine
Oral live attenuated Ty21a vaccine
Vi-rEPA vaccine
Indian Prespective
Key Points
22:
Yellow Fever Vaccine
Epidemiology
Clinical Spectrum of Yellow Fever
Laboratory Spectrum of Yellow Fever
‘Nuts and Bolts’ of Yellow Fever Vaccination
Type of Vaccine
Dosage and Protection of Vaccine
Safety Issues
Hazards to Visitors in Endemic Areas
Legal Requirement in India
Key Points
23:
Tuberculosis Vaccine: Immunology, Strategies and Status
Infection and Disease
Mycobacterium Tuberculosis – Survival Strategies
Immune Response and the need of Vaccine
Innate Mechanisms
Cell Mediated Immune Response
Types of Vaccine
Prophylactic Vaccine
Post-exposure or Immunotherapeutic Vaccines
Tuberculosis Vaccines: Approaches and Status
BCG vaccine: Limitations and lessons
DNA vaccines
Subunit vaccines
Avirulent Mycobacteria as vaccines
Attenuated Live Vaccine Based on PhoP
Modified or Recombinant BCG (rBCG)/ Prime-Boost Regimens
New TB Vaccines: Ongoing Clinical Trials Worldwide
Priming
Boosting
Vaccine Based Immunotherapy
Key Points
24:
Varicella and Herpes Zoster Vaccines
Varicella in Pregnancy and in Neonates
Mortality
Immune Response to Varicella Infection
Herpes Zoster
Laboratory Diagnosis
When is a laboratory test necessary?
Treatment and Protection of Contacts
Varicella Zoster Immunoglobulin
Indications and usage
Contraindications
Adverse reactions
Dosage and administration
Can Varicella Vaccine Prevent Herpes Zoster?
Varicella Vaccines
Vaccine schedule
Adverse events
Contraindications
Students going to the USA for studies
Control of Varicella
Global scenario
Seroprevalence of varicella antibodies in temperate and tropical countries
Indian perspective
Herpes Zoster Vaccine
Key Points
INDEX
TOC
Index
×
Chapter Notes
Save
Clear